This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: The Innovations of Ruben Jose Crespo-Diaz
Introduction
Ruben Jose Crespo-Diaz is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of cardiac health, holding a total of 4 patents. His work focuses on improving cardiac function and reducing the risk of major adverse cardiac events.
Latest Patents
Crespo-Diaz's latest patents include innovative methods for enhancing cardiac function. One of his patents, titled "Method of using NAP-2 and TGF-α to improve cardiac function," provides methods and materials for identifying patients at risk of experiencing major adverse cardiac events. This includes treatment options for patients who have undergone percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI). Another significant patent, "Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function," similarly addresses the identification and treatment of patients at risk for major adverse cardiac events.
Career Highlights
Crespo-Diaz is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and innovations in cardiac health. His work is instrumental in developing new methods to improve patient outcomes in cardiology.
Collaborations
Crespo-Diaz collaborates with esteemed colleagues such as Atta Behfar and Andre Terzic, contributing to a rich environment of innovation and research in the medical field.
Conclusion
Ruben Jose Crespo-Diaz is a pioneering inventor whose work in cardiac health is making a significant impact. His patents and collaborations reflect his commitment to improving patient care and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
